| Title |
Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, August 2021
|
| DOI | 10.1158/1535-7163.mct-21-0109 |
| Pubmed ID | |
| Authors |
Alison R Mercer-Smith, Wulin Jiang, Juli R Bago, Alain Valdivia, Morrent Thang, Alex S Woodell, Stephanie A Montgomery, Kevin T Sheets, Carey K Anders, Shawn D Hingtgen |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 1 | 10% |
| Researcher | 1 | 10% |
| Unknown | 8 | 80% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 1 | 10% |
| Neuroscience | 1 | 10% |
| Medicine and Dentistry | 1 | 10% |
| Unknown | 7 | 70% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2021.
All research outputs
#3,276,675
of 25,054,594 outputs
Outputs from Molecular Cancer Therapeutics
#466
of 4,054 outputs
Outputs of similar age
#72,129
of 423,281 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#7
of 55 outputs
Altmetric has tracked 25,054,594 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,054 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,281 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.